NURS-6521N-14 Advanced Pharmacology Exam_2022 || 94 out of 100 Points
A 51-year-old female patient has been receiving doxorubicin (Adriamycin) for metastatic breast cancer. Her medical record indicates she has cardiomyopathy and a cumulative dose of 300 mg/m2 of doxorubicin. Which of the following measures would help limit the severity of the cardiomyopathy in this patient? Selected Answer: The use of dexrazoxane in conjunction with doxorubicin NURS-6521N-14 Advanced Pharmacology Exam_2022 Winter Qtr 11 25-02/16-PT27 Exam – Week 11 94 out of 100 Points Review Test Submission Exam – Week 11 A patient with non-Hodgkin's lymphoma (NHL) will be starting a course of doxorubicin shortly. When planning this patient's care, what nursing diagnosis should the nurse prioritize? Selected Answer: Risk for Infection related to suppressed bone marrow function
Geschreven voor
- Instelling
- NURS-6521N-14
- Vak
- NURS-6521N-14
Documentinformatie
- Geüpload op
- 15 november 2022
- Aantal pagina's
- 46
- Geschreven in
- 2022/2023
- Type
- Tentamen (uitwerkingen)
- Bevat
- Vragen en antwoorden
Onderwerpen
-
nurs 6521n 14
-
advanced pharmacology
-
advanced pha
-
nurs 6521n 14 advanced pharmacology exam2022 || 94 out of 100 points
-
nurs 6521n 14 advanced pharmacology exam2022
-
nurs 6521n 14 advanced pharmacology